Literature DB >> 17169595

Small airway relaxation--a forgotten medical need.

Carl G A Persson1.   

Abstract

The current exclusive focus on airway inflammation and remodelling in asthma and chronic obstructive pulmonary disease has dwarfed the interest in simple relaxation of the bronchi. This commentary highlights the particular importance of reducing smooth muscle constriction of human small airways in these obstructive diseases. Furthermore, the need of novel drugs in this area is underscored by in vitro and in vivo data demonstrating limited small airway relaxant efficacy of currently available bronchodilators.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169595     DOI: 10.1016/j.pupt.2006.10.017

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  3 in total

1.  Novel small airway bronchodilator responses to rosiglitazone in mouse lung slices.

Authors:  Jane E Bourke; Yan Bai; Chantal Donovan; James G Esposito; Xiahui Tan; Michael J Sanderson
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

2.  Rhinovirus and dsRNA induce RIG-I-like receptors and expression of interferon β and λ1 in human bronchial smooth muscle cells.

Authors:  Jenny Calvén; Yuliana Yudina; Lena Uller
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

3.  Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices.

Authors:  Chantal Donovan; Mirjam Simoons; James Esposito; Jean Ni Cheong; Meaghan Fitzpatrick; Jane Elizabeth Bourke
Journal:  Respir Res       Date:  2014-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.